Evidence map›Paper›PMID 28123238›Full record

ArticleMedical journal, Armed Forces India2017

Predictors of first line antiretroviral therapy failure and burden of second line antiretroviral therapy.

Seema Patrikar, Subramanian Shankar, Atul Kotwal, D R Basannar, Vijay Bhatti, Rajesh Verma, Sandip Mukherji

Open access · bronzeAbstract read
In one paragraph

Article in Medical journal, Armed Forces India, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Ending AIDS: The 90-90-90 strategy.Medical journal, Armed Forces India · 2017
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Seema PatrikarLecturer in Statistics, Dept of Community Medicine, Armed Forces Medical College, Pune 411040, India.
Subramanian ShankarSenior Advisor (Medicine & Clinical Immunology), Command Hospital (Air Force) Bengaluru, India.
Atul KotwalDy DGAFMS (Pension), O/o DGAFMS, Ministry of Defence, 'M' Block, New Delhi, India.
D R BasannarScientist 'F', Dept of Community Medicine, Armed Forces Medical College, Pune 411040, India.
Vijay BhattiDirector Medical Services (Health), O/o DGAFMS, Ministry of Defence, New Delhi, India.
Rajesh VermaConsultant (Dermatology), Base Hospital, Lucknow, UP, India.
Sandip MukherjiProfessor & Head, Dept of Community Medicine, Armed Forces Medical College, Pune 411040, India.
Armed Forces Medical College · INMinistry of Defence · INCommand Hospital Air Force · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAs HIV steps into the third decade, there are more number of patients living on lifelong (antiretroviral therapy) ART and facing the threat of drug resistance with subsequent treatment failure. The aim of this study was to determine predictors of first-line ART failure with the objectives to estimate the burden of 2nd line ART.

methodsA retrospective 5-year cohort of HIV patients who were initiated on first line ART in 2008-09 was studied. Patients were followed from the time of ART initiation. Kaplan-Meier methods and Cox proportional hazards regression models were used to estimate probabilities and predictors of first line ART failure.

resultsOf the total of 195 patients initiated on first line ART, 15 patients were switched to second line ART yielding 7.69% failure rate. During the 7178 person-years of follow-up, the incidence of first line ART failure was 2.09 per 1000 person-years. The Kaplan-Meier survival analysis gave a mean survival time of 55.6 months. BMI, CD4 count at ART initiation and presence of opportunistic infections were significant predictors of first line ART failure. The burden of second line ART patients by the end of 5 years of first line ART is expected to be 151 patients.

conclusionThough the first line ART failure is quite low in this study, we still need to be vigilant for lower BMI, low baseline CD4 count and occurrence of opportunistic infections to efficiently manage failures on first line ART.

Indexed as

Antiretroviral therapyFirst line ART failureHuman immunodeficiency virusSurvival

Identifiers

PMID28123238
PMCPMC5221360
OpenAlexW2558862789

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.